Literature DB >> 24004450

HLA and disease: guilt by association.

W M Howell1.   

Abstract

It is now over forty years since the first associations between particular HLA antigens and disease susceptibility were described, and the identification of large numbers HLA-associated diseases parallels our increased understanding of the genetic complexity of the HLA system and its extensive polymorphism. However, surprisingly and frustratingly, clear identification of the underlying mechanisms resulting in a causative role for HLA polymorphism in the molecular immunopathogenesis of individual HLA-associated diseases remains the exception rather than the rule. This review, while not intended to be a comprehensive catalogue of HLA-associated diseases, aims to revisit a number of well known and more recently described HLA-associated diseases as exemplars of our current understanding of the underlying molecular mechanisms which may result in genetic disease predisposition. Such mechanisms may act as pointers for further investigations in other HLA-associated diseases. The clinical utility of specific HLA disease associations in disease diagnosis/exclusion is also considered.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24004450     DOI: 10.1111/iji.12088

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  21 in total

1.  Human leukocyte antigen-DRB1 polymorphism in childhood acute lymphoblastic leukemia.

Authors:  Mervat M El Ansary; Lamiaa A Mohammed; Tamer H Hassan; Ahmed Baraka; Alshymaa A Ahmed
Journal:  Mol Clin Oncol       Date:  2014-11-25

2.  HLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM.

Authors:  Rathika Chinniah; Vandit Sevak; Sasiharan Pandi; Padma Malini Ravi; Murali Vijayan; Arun Kannan; Balakrishnan Karuppiah
Journal:  Immunogenetics       Date:  2021-03-22       Impact factor: 2.846

Review 3.  More than 25 years of genetic studies of clozapine-induced agranulocytosis.

Authors:  S A J de With; S L Pulit; W G Staal; R S Kahn; R A Ophoff
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

4.  The Concept of Immunogenetics.

Authors:  Fateme Rajabi; Navid Jabalameli; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Association of HLA-DPA1 polymorphism with prolonged mechanical ventilation in patients undergoing liver transplantation.

Authors:  Eun Jung Kim; Min-Soo Kim; Myoung Soo Kim; Junhyun Nam; Seung Ho Choi
Journal:  Korean J Anesthesiol       Date:  2022-05-03

Review 6.  New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.

Authors:  Aaron W Michels; David A Ostrov
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

7.  Association of HLA-DQA1 gene polymorphisms with the risk of children primary nephrotic syndrome in Chinese population.

Authors:  Bingbing Zhu; Ruifeng Zhang; Huandan Yang; Tingting Yuan; Juan Lv; Qianqian Peng; Lijun Tian
Journal:  J Clin Lab Anal       Date:  2018-07-13       Impact factor: 2.352

8.  Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women.

Authors:  Jean-Claude Tardif; Marie-Pierre Dubé; Maxine Sun; Audrey Lemaçon; Marc-André Legault; Géraldine Asselin; Sylvie Provost; Hugues Aschard; Amina Barhdadi; Yassamin Feroz Zada; Diane Valois; Ian Mongrain
Journal:  Pharmacogenomics J       Date:  2021-03-01       Impact factor: 3.550

9.  Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.

Authors:  James R Cerhan; Sonja I Berndt; Joseph Vijai; Hervé Ghesquières; James McKay; Sophia S Wang; Zhaoming Wang; Meredith Yeager; Lucia Conde; Paul I W de Bakker; Alexandra Nieters; David Cox; Laurie Burdett; Alain Monnereau; Christopher R Flowers; Anneclaire J De Roos; Angela R Brooks-Wilson; Qing Lan; Gianluca Severi; Mads Melbye; Jian Gu; Rebecca D Jackson; Eleanor Kane; Lauren R Teras; Mark P Purdue; Claire M Vajdic; John J Spinelli; Graham G Giles; Demetrius Albanes; Rachel S Kelly; Mariagrazia Zucca; Kimberly A Bertrand; Anne Zeleniuch-Jacquotte; Charles Lawrence; Amy Hutchinson; Degui Zhi; Thomas M Habermann; Brian K Link; Anne J Novak; Ahmet Dogan; Yan W Asmann; Mark Liebow; Carrie A Thompson; Stephen M Ansell; Thomas E Witzig; George J Weiner; Amelie S Veron; Diana Zelenika; Hervé Tilly; Corinne Haioun; Thierry Jo Molina; Henrik Hjalgrim; Bengt Glimelius; Hans-Olov Adami; Paige M Bracci; Jacques Riby; Martyn T Smith; Elizabeth A Holly; Wendy Cozen; Patricia Hartge; Lindsay M Morton; Richard K Severson; Lesley F Tinker; Kari E North; Nikolaus Becker; Yolanda Benavente; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadie; Anthony Staines; Tracy Lightfoot; Simon Crouch; Alex Smith; Eve Roman; W Ryan Diver; Kenneth Offit; Andrew Zelenetz; Robert J Klein; Danylo J Villano; Tongzhang Zheng; Yawei Zhang; Theodore R Holford; Anne Kricker; Jenny Turner; Melissa C Southey; Jacqueline Clavel; Jarmo Virtamo; Stephanie Weinstein; Elio Riboli; Paolo Vineis; Rudolph Kaaks; Dimitrios Trichopoulos; Roel C H Vermeulen; Heiner Boeing; Anne Tjonneland; Emanuele Angelucci; Simonetta Di Lollo; Marco Rais; Brenda M Birmann; Francine Laden; Edward Giovannucci; Peter Kraft; Jinyan Huang; Baoshan Ma; Yuanqing Ye; Brian C H Chiu; Joshua Sampson; Liming Liang; Ju-Hyun Park; Charles C Chung; Dennis D Weisenburger; Nilanjan Chatterjee; Joseph F Fraumeni; Susan L Slager; Xifeng Wu; Silvia de Sanjose; Karin E Smedby; Gilles Salles; Christine F Skibola; Nathaniel Rothman; Stephen J Chanock
Journal:  Nat Genet       Date:  2014-09-28       Impact factor: 41.307

10.  Genetic markers as a predictive tool based on statistics in medical practice: ethical considerations through the analysis of the use of HLA-B(*)27 in rheumatology in France.

Authors:  Hélène Colineaux; Adeline Ruyssen-Witrand; Anne Cambon-Thomsen
Journal:  Front Genet       Date:  2015-10-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.